HSPG2 and endothelial dysfunction: Since HSPGs have been proposed to be antiatherogenic [46], we can suggest that elevated circulating HS/H levels, mainly due to increased arterial HSPG degradation, may be an important indicator of endothelial dysfunction in RA patients.